Caris Life Sciences, Inc. (CAI)
23.04
-0.92
(-3.84%)
USD |
NASDAQ |
Nov 13, 16:00
23.04
0.00 (0.00%)
After-Hours: 19:59
Caris Life Sciences Profit Margin (Quarterly) : 5.54% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 5.54% |
| June 30, 2026 | -0.24% |
| March 31, 2026 | -0.24% |
| December 31, 2025 | 27.98% |
| September 30, 2025 | 11.22% |
| June 30, 2025 | -39.58% |
| Date | Value |
|---|---|
| March 31, 2025 | -84.84% |
| December 31, 2024 | -28.44% |
| September 30, 2024 | -66.65% |
| June 30, 2024 | -66.15% |
| March 31, 2024 | -137.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Natera, Inc. | -7.55% |
| Myriad Genetics, Inc. | -21.66% |
| BioRestorative Therapies, Inc. | -9.29K% |
| CareDx, Inc. | 13.84% |
| Exagen, Inc. | -34.40% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 16.67% |
| Return on Assets | 8.34% |
| Return on Invested Capital | 9.45% |
| Gross Profit Margin (Quarterly) | 66.20% |
| Operating Margin (Quarterly) | 7.01% |
| Return on Net Operating Assets | 30.49% |